Understanding and Managing Eczema and Chronic Hives
Eczema & Urticaria: What They Are, How They're Treated
Eczema and hives (urticaria) represent two of the most frustrating skin conditions encountered in clinical practice. While their causes and appearances differ, both share a defining characteristic: a debilitating itch that can significantly decrease a patient’s quality of life.
Eczema: The "Itch That Rashes"
Atopic dermatitis, commonly known as eczema, is frequently described as "the itch that rashes" because the act of scratching triggers visible inflammatory changes in the skin. While some people may suspect childhood vaccines are responsible for eczema, clinical studies have shown otherwise. Vaccines can, however, stimulate the immune system upon initial injection and trigger a mild but brief flare.
- Clinical Presentation: Eczema typically appears as scaly, dry skin that can ooze and crust during severe flares.
- Duration: Unlike other skin conditions, an eczema flare does not resolve in hours; it typically persists for days, weeks, or longer.
- Distribution: Due to a defect in the skin barrier, eczema can appear anywhere on the body from head to toe.
Clinical Management of Eczema
Effective management is built upon a foundation of rigorous skin care designed to break the itch-scratch cycle.
- The "Soak and Smear" Technique: This involves hydrating the skin in a warm bath and immediately applying a thick emollient, such as Cetaphil®, CeraVe®, or Eucerin®, to lock in moisture.
- Physical Protection: Especially for pediatric patients, keeping fingernails short and smooth or using cotton or silk gloves can prevent skin damage during sleep.
- Topical Therapies: Options include varying potencies of steroids, calcineurin inhibitors (Protopic® or Elidel®), phosphodiesterase inhibitors, and newer JAK inhibitors. (Janus kinase inhibitors are a class of targeted, small molecule medications that treat autoimmune and inflammatory diseases. By interrupting signaling pathways, they reduce inflammation and help manage certain conditions, like eczema.)
- Advanced Biologics: For severe cases, injectable biologics like Dupixent® and NEMLUVIO® have proven life-changing by targeting specific inflammatory pathways.
Hives: Transient and Mobile
Urticaria, or hives, is distinguished by the rapid appearance and disappearance of welts.
- Clinical Presentation: Individual hives are fleeting, typically lasting less than 24 hours before moving to a different location.
- Acute vs. Chronic: Acute hives often have an identifiable allergic trigger. However, chronic urticaria—hives occurring daily for six weeks or more—is rarely caused by an allergy.
- Underlying Causes: Chronic cases are often autoimmune or idiopathic, though rare cases may involve urticarial vasculitis, marked by systemic symptoms like fever and bruising.
- Physical Triggers: Hives can be induced by physical stimuli such as heat, cold, pressure, vibration, or scratching the skin.
Treatment Pathways for Hives
- Antihistamines: High-dose second-generation antihistamines serve as the primary treatment.
- Targeted Therapies:
When antihistamines are insufficient, medications such as Rhapsido® or the biologics Xolair or Dupixent are utilized.
The Role and Safety of Biologics
The biologics used to treat eczema and hives have revolutionized patient care. Unlike traditional immunosuppressants used for conditions like rheumatoid arthritis, these medications are not broadly immunosuppressive. Instead, they disrupt specific inflammatory pathways (targeting IgE or eosinophils) to control the disease without increasing the general risk of infection.
Common side effects are typically manageable and may include mild headaches, joint aches, or conjunctivitis. For many patients, these advanced treatments provide the necessary relief to end social isolation and restore a normal quality of life.
(This blog post is an adaptation of a Let's Clear the Air! podcast episode airing on April 20, 2026.)
You might also like
